|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Congenital Heart Surgery Service, Texas Children's Hospital, Baylor College of Medicine, 6221 Fannin St, Mail Code: WT 19345-H, Houston, TX 77030-2399
(Email: charlesf@bcm.tmc.edu).
| The first 20% of the full text of this article appears below. |
Is there controversy remaining in the surgical treatment of tetralogy of Fallot (TOF)? Can we continue to modify our approach to these patients and improve their short-term and long-term prognosis? This report of 28 years of experience with TOF with atrioventricular septal defect (AVSD) underscores the fact that there is still much room for refinement [1].
Tetralogy of Fallot with AVSD is a complex constellation of lesions, historically associated with challenging operative correction and variable, but significant perioperative risk. In many ways, this association is the "ultimate" form of TOF. Operative risk is exacerbated by the very large ventricular septal defect patch required for the malaligned ventricular septal defect component, as well as atrioventricular valve reconstruction, and right ventricular outflow tract (RVOT) resection with or without pulmonary valvotomy and transannular incision. Unnecessary or avoidable compromise of the reconstructed
Related Article
Ann. Thorac. Surg. 2008 85: 1686-1689.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |